SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

iBio, Inc. (IBIO)

Add IBIO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/8/2017 9:25:17 PM - Followers: 226 - Board type: Free - Posts Today: 0



About us

iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBioLaunch™ platform. The iBioLaunch platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. It uses proprietary, transient gene expression in unmodified green plants instead of materials such as chicken eggs, mammalian and insect cells, transgenic plants, and human blood plasma required by other systems, to produce important biologic pharmaceuticals. This unique plant-based platform offers a number of significant advantages over other systems:
  • Ability to synthesize complex proteins at which other systems have failed
    Simplicity, scalability and flexibility
    Reduced capital investment
    Lower operating costs
    Surge capacity
    Rapid production times – gene sequence to factory-scale protein harvest
    Eliminates the need of bioreactors
    Low risk of contamination by animal pathogens

iBio has a strong IP/technology portfolio and has been well established by more than nine years of applications development and $100 million in funding. Our current pipeline includes:

Monoclonal antibodies
Interferons & cytokines
Enzymes for replacement therapy
Plasma-derived proteins
Growth factors
Protease inhibitors
Clotting factors


The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and reliably scaled-up in low cost, controlled growth facilities to produce large amounts of recombinant protein in the plant biomass.  The technology is highly flexible having the capability to produce both biotherapeutics and vaccines. Advantages of the whole plant approach include lower operating and capital expenses compared to protein production using engineered microbial or animal cells in bioreactors. The iBioLaunch platform offers significant advantages over earlier plant-based methods that rely on transgenic plants or plant cell cultures. These include the speed at which different proteins can be expressed and produced at commercial scale, which presents a significant commercial advantage, as well as public safety benefits when vaccines for pandemic diseases are required.  Other advantages include scalability, no risks of contamination by animal pathogens, and the ability to express complex proteins at which other systems have failed.

The iBioLaunch technology platform addresses several multi-billion dollar markets.  Its applicability to a broad range of product classes enables iBio to target global commercial collaborations in high-growth markets such as orphan biologics ($54.6 billion in 2009), biosimilars/bio-betters (~$80 billion worth of biologics sales will be susceptible to biosimilar competition, by 2013) and new proprietary biologics. The speed and superior economic scalability of the iBioLaunch™ technology make it the ideal platform for new personalized therapeutics as well as for vaccines ($32 billion in 2013).

Our technology has been validated across a wide range of applications in both vaccines and biotherapeutics, and these products are available for license along with the technology to bring innovative medicines to patients.




iBio’s business strategy is to broadly participate in the markets that the iBioLaunchTM platform addresses. We will establish partnerships through product collaborations and platform licensing arrangements. iBio is well-positioned to facilitate the advanced development of products based on the iBioLaunch platform or  to assist in the turn-key implementation of the iBioLaunch technology by our partners.

We have developed a pipeline of clinical and phase I-ready products that use the iBioLaunch platform across various classes and diseases.

iBio offers collaborations with biotechnology and pharmaceutical companies through:

Out-licensing our pipeline of products produced with the iBioLaunch platform
Partnering our technology for exploratory, research or validation studies
Out-licensing the iBioLaunch platform for the production of biotherapeutics and vaccines

For additional information, please contact:

Douglas Hicks
Vice-President, Business Development
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
IBIO News: Current Report Filing (8-k) 03/06/2017 05:01:57 PM
IBIO News: Statement of Changes in Beneficial Ownership (4) 02/27/2017 03:41:19 PM
IBIO News: Amended Statement of Beneficial Ownership (sc 13d/a) 02/27/2017 03:34:20 PM
IBIO News: Current Report Filing (8-k) 02/24/2017 05:04:46 PM
IBIO News: Quarterly Report (10-q) 02/21/2017 04:06:17 PM
#15279 IveBeenBagged 03/08/17 09:25:17 PM
#15278   Bird flue? New board member? Why mandakaman 03/07/17 09:24:25 PM
#15277   Up soon brbpab94 01/22/17 08:59:22 PM
#15276   They have a settled case and you will brbpab94 01/22/17 08:58:42 PM
#15275   How low? Subpenny eventually. Until then, just more Mokyo Toe 01/19/17 11:48:09 AM
#15274   Up or down? 0.20 or $100? Let me IveBeenBagged 01/12/17 05:08:55 PM
#15273   I think we might see the .20's soon. Top Penny 01/12/17 01:02:33 PM
#15272   Trending higher, I like Top Penny's idea of Investor 35 01/05/17 07:14:04 PM
#15271   IBIO will one day be a hundred dollar Top Penny 01/04/17 02:25:41 PM
#15270   Getting close to upper resistance. Watch for possible breakout. IveBeenBagged 12/31/16 11:58:02 AM
#15269   go out or go in bero23 11/29/16 02:20:39 PM
#15268   the charts say go biowatcher 11/26/16 10:08:01 AM
#15267   VOLUME ? beambe 11/25/16 10:52:38 AM
#15266 surfnsk8 11/17/16 09:28:35 AM
#15265   Is there no news from yesterday? harmsen 11/15/16 08:31:02 AM
#15264   iBio Expands Product Development Capacity of cGMP Plant harmsen 11/10/16 09:19:56 AM
#15263   Program trading takes it down. willlbone 11/03/16 02:19:51 PM
#15262 errett 10/25/16 05:43:08 AM
#15261   SOURCE: iBio, Inc. September 29, 2016 08:30 ET NEW YORK, TORO 09/29/16 09:19:59 AM
#15260   SOURCE: iBio, Inc. ? September 29, 2016 08:30 ET iBio Proprietary TORO 09/29/16 08:47:51 AM
#15259   Harmsen---as of 03/16----$17.6 million in cash from sale errett 09/13/16 12:19:44 PM
#15258   How many cash has the company?Thank you harmsen 09/13/16 06:49:17 AM
#15257   IBIO bullish 0.5921 stocktrademan 09/02/16 04:48:53 PM
#15256   IBIO will one day be a hundred dollar stock. Top Penny 08/19/16 03:02:30 PM
#15255 errett 08/12/16 09:19:34 AM
#15254   Good News: errett 08/05/16 11:09:08 AM
#15253   Keep watching the turn will come. biowatcher 07/26/16 03:05:44 AM
#15252   I'm not seeing anything but downward pressure. Investor 35 07/25/16 07:52:44 PM
#15251   Nothing but blue skies do I see....soon! biowatcher 07/21/16 04:32:08 PM
#15250   Sentiment for Ibio Inc (NYSEMKT:IBIO) errett 07/15/16 06:47:34 AM
#15249   Here is all the dd for this stock: longhorn4lif 07/08/16 10:17:01 PM
#15248   sold out. ash111 07/08/16 02:50:09 PM
#15247   what catalysts could drive pps up? ash111 07/08/16 11:10:09 AM
#15246   official:iBio, Inc. Receives FDA Orphan Drug Designation for ash111 07/05/16 03:00:00 PM
#15245   iBio, Inc. Receives FDA Orphan Drug Designation for ash111 07/05/16 02:17:11 PM
#15244   .60 to .65 as been great support and longhorn4lif 07/01/16 10:08:26 AM
#15243   Thank you.on watch ash111 07/01/16 06:02:24 AM
#15242   PR & newswire tomorrow for FDA news? remind2 06/30/16 09:25:11 PM
#15241   Designated orphan status....not approved longhorn4lif 06/30/16 06:59:05 PM
#15240   you meant this ? ash111 06/30/16 03:00:07 PM
#15239   Smart folks loading! longhorn4lif 06/30/16 01:53:30 PM
#15238   IBIO: FDA approved Orphan Drug Status 6/27/16. No remind2 06/30/16 09:46:33 AM
#15237   Top Penny, it was a very strong day KobeF 06/15/16 04:09:08 PM
#15236   Yea i saw the patent want the news.....thats longhorn4lif 06/15/16 08:00:51 AM
#15235   Fibrosis patent news is out. IBIO to announce Lucathewolf 06/15/16 06:37:59 AM
#15234   Very good day....maybe gets some fibrosis news tomorrow! longhorn4lif 06/14/16 07:39:55 PM
#15233   Yep and its a good source longhorn4lif 06/10/16 09:16:29 AM
#15232   I was just kidding with you, either way Blue Sky Basin 06/10/16 09:13:04 AM
#15231   Nice find.....i was so excited after reading i longhorn4lif 06/10/16 08:41:14 AM
#15230   Lol sorry didny even see it longhorn4lif 06/10/16 08:38:09 AM